Norwegian National Air Ambulance Services Choose Danish Blood/IV Fluid Warmer, ̊M Warmer System ( ̊MEQU)

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

March 22, 2021

Norwegian National Air Ambulance Services

 

˚MEQU, an innovative MedTech company from Denmark, is pleased to announce that it has won a public tender to provide portable blood and IV-fluid warming devices (˚M Warmer System) to Norwegian National Air Ambulance Services (Luftambulansetjenesten HF). 

Norwegian National Air Ambulance Services is responsible for all air ambulances (both fixed-wing and helicopters) and acute cars located at 13 bases throughout the country and is one of the most innovative and advanced HEMS (helicopter emergency medical services) programs in the world. The ˚M Warmer System was the only device meeting all mandatory requirements and was chosen due to its high quality – small size and light weight, heating capacity, and not least user-friendliness.

Prehospital fluid resuscitation is known to increase the survival rate of trauma patients. For this reason, carrying blood products onboard aircraft has been initiated by major European HEMS in recent years despite its complex and costly process in terms of blood supply and staff training. Moreover, aircraft should be equipped with a blood/IV fluid warmer as all fluids should be warmed up to body temperature before the infusion to avoid unnecessary cooling of the patient.

Ulrik Krogh Andersen (CEO) commented,“prehospital fluid resuscitation before arriving at a hospital is shown to significantly reduce mortality among severely injured patientsWe are thankful that Norwegian National Air Ambulance Services chose our ˚M Warmer System to treat their patients, so we accelerate our mission to improve the survival and recovery rate of patients in critical situations.”

Peter Skade (GLOBAL SALES DIRECTOR) commented, “winning this tender is a confirmation that ˚M Warmer System is a superior solution as it is easy to set up and use and has efficient and powerful warming capacity. The ˚M Warmer System is now adopted by leading HEMS throughout the Nordic countries, UK, mainland Europe and Australia.”

The ˚M Warmer System was awarded the Red Dot Design Award in 2018 for its minimalist expression, user-friendliness, and intuitive design that together reduce the risk of human errors and delays. ˚M Warmer is currently used both in pre-hospital and in-hospital settings, and ˚MEQU is continuously developing its technology to bring warm blood and IV fluids to more patients.

spot_img

DON'T MISS

Related Articles